The origin and distribution of CD68, CD163, and αSMA+cells in the early phase after meniscal resection in a parabiotic rat model.
We previously reported that circulating peripheral blood-borne cells (PBCs) contribute to early-phase meniscal reparative change. Because macrophages and myofibroblasts are important contributors of tissue regeneration, we examined their origin and distribution in the reparative meniscus. Reparative menisci were evaluated at 1, 2, and 4 weeks post-meniscectomy by immunohistochemistry to locate monocytes and macrophages (stained positive for CD68 and CD163), and myofibroblasts (stained positive for αSMA). Of the total number of cells, 13% were CD68+at 1 week post-meniscectomy, which decreased to 1% by 4 weeks post-meniscectomy; of these, almost half of CD68+cells (49.4%: 98.8% as PBCs) were green fluorescent protein (GFP)-positive post-meniscectomy (1, 2, and 4 weeks), indicating that the majority of CD68+cells were derived from PBCs. Of the total cells, 6% were CD163+at 1 week post-meniscectomy, which decreased to 1% by week 4. Of the CD163+cells, the majority were GFP-positive (42.5%: 85.0% as PBCs) after 1 week; however, this decreased significantly over time, which indicates that the majority of CD163+cells are derived from PBCs during the early phase of meniscal reparative change, but are derived from resident cells at later time points. Of the total cells, 38% were αSMA+at 1 week post-meniscectomy, which decreased to 3% by 4 weeks. The proportion of GFP-positive αSMA+cells was 2.8% after 1 week, with no significant change over time, which indicates that the majority of αSMA+cells originated from resident cells. Here, we describe the origin and distribution of macrophages and myofibroblasts during meniscal reparative change.
a Department of Orthopaedic Surgery , Osaka City University Graduate School of Medicine , Osaka , Japan.
Shozaburo
S
Terai
a Department of Orthopaedic Surgery , Osaka City University Graduate School of Medicine , Osaka , Japan.
Yusuke
Y
Hashimoto
a Department of Orthopaedic Surgery , Osaka City University Graduate School of Medicine , Osaka , Japan.
Kumi
K
Orita
b Department of Orthopaedic Surgery , Osaka City General Hospital , Osaka , Japan.
Shinya
S
Yamasaki
c Department of Orthopaedic Surgery , Shimada Hospital , Habikino , Japan.
Junsei
J
Takigami
a Department of Orthopaedic Surgery , Osaka City University Graduate School of Medicine , Osaka , Japan.
Takafumi
T
Shinkuma
a Department of Orthopaedic Surgery , Osaka City University Graduate School of Medicine , Osaka , Japan.
Takanori
T
Teraoka
a Department of Orthopaedic Surgery , Osaka City University Graduate School of Medicine , Osaka , Japan.
Yohei
Y
Nishida
d Division of Inflammation Research, Centre for Molecular Medicine , Jichi Medical University , Shimotsuke , Japan.
Masafumi
M
Takahashi
a Department of Orthopaedic Surgery , Osaka City University Graduate School of Medicine , Osaka , Japan.
Hiroaki
H
Nakamura
D000818:Animals; D015703:Antigens, CD / Q000378:metabolism*; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism*; D005260:Female; D049452:Green Fluorescent Proteins / Q000378:metabolism; D007150:Immunohistochemistry / Q000379:methods; D008264:Macrophages / Q000378:metabolism*; D000074403:Meniscectomy / Q000379:methods; D008592:Menisci, Tibial / Q000166:cytology*; D000072600:Meniscus / Q000166:cytology*; D055647:Rats, Transgenic; D011956:Receptors, Cell Surface / Q000378:metabolism*; D014945:Wound Healing / Q000502:physiology; D000098902:CD163 Antigen; D000097382:CD68 Molecule
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D049452:Green Fluorescent Proteins; D011956:Receptors, Cell Surface; D000098902:CD163 Antigen; C539355:CD68 protein, rat; D000097382:CD68 Molecule
CD163; CD68; macrophage; meniscus; myofibroblast